Research Alerts

The latest publications on EDS from PubMed the most trusted source for medical research

Ehlers-Danlos syndrome

  • Kumskova M, Flora GD, Nayak MK, et al. Platelet defects in patients and mice with Ehlers-Danlos syndrome. Blood. 2026;147(9):987-997
    Published: Jun 04, 2026

    No abstract

  • Treating Pain and Trauma: A Systematic Review of Non-randomized Studies of Psychotherapeutic Approaches
    Published: Jun 04, 2026
    Author: Rachael Bosma, Kathryn Curtis, Callon Williams, P Maxwell Slepian, Molly McCarthy, Michelle Flynn, Adriano Nella, Alice Kim, Rachel Siegal, Marina Englesakis, Karim Ladha, Tania Di Renna, Brittany N Rosenbloom

    The co-occurrence of chronic pain and trauma symptoms is prevalent; thus treatment approaches that address both are required. This systematic review of non-randomized studies aims to describe available psychotherapeutic interventions that concurrently target chronic pain and trauma-related symptoms for adults. Five databases (MEDLINE, Embase, the Cochrane Central Register of Controlled Trials, the Cochrane Database of Systematic Reviews, PsycINFO) were searched from date of inception until...

  • Psychoactive medication use and cardiac electrophysiology in hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorder: a retrospective analysis
    Published: Jun 04, 2026
    Author: Riya Kaushal, Ian Snyder, Ermin Tale, Liat Jarkon, Bernadette Riley, Todd J Cohen

    CONCLUSIONS: hEDS patients had a higher psychiatric burden and psychoactive medication use than HSD patients, but ECG parameters largely remained within normal limits. The increased QTc prolongation in HSD patients highlights potential cardiovascular risks, requiring further investigation. Routine cardiovascular monitoring and interdisciplinary care are recommended for hypermobile patients on psychoactive medications.

  • Lipodermatosclerosis-like clinical presentation with PXE-like histopathology in a patient with newly diagnosed vascular Ehlers-Danlos syndrome
    Published: Jun 03, 2026
    Author: Olivia Graham, Kavish Singh, Peter Chow, Urmi Khanna

    No abstract

  • Open Capsular Shift with Achilles Allograft Augmentation for Multidirectional Shoulder Instability: Long-Term Outcomes and Implications for Patients with Ehlers-Danlos Syndrome
    Published: Jun 03, 2026
    Author: Serge B Albarian, Paula M P Trinh, Lauren Simonian, Karthik Nathan, Claire D Eliasberg, Scott A Rodeo

    CONCLUSION: Open capsular shift with Achilles tendon allograft augmentation can be an effective procedure for restoring long-term shoulder stability and functionality in patients with MDI, including those with connective tissue disorders such as EDS.

  • Comorbidities in Ehlers-Danlos syndromes and hypermobile spectrum disorders
    Published: Jun 02, 2026
    Author: T J Wang, A M Serrano-Ardila

    CONCLUSIONS: the lower MCAS prevalence in SpA + EDS may reflect symptom overlap or suppression due to immunomodulatory treatments. Differences in medication use highlight variations in diagnostic and therapeutic strategies. Comprehensive evaluations are essential to ensure accurate diagnoses and optimal treatment approaches.

  • Single-port robotic nephropexy for symptomatic nephroptosis in a young female: A case report
    Published: Jun 01, 2026
    Author: Kerri A Kendrick, Eric Umbreit

    A 21-year-old woman with Ehlers-Danlos syndrome presented with symptomatic right renal mobility. Standing IV pyelogram demonstrated a 7 cm descent of the right kidney without hydronephrosis. She underwent a retroperitoneal single-port nephropexy without complications. At three months, imaging confirmed stable renal position with complete symptom resolution. This case highlights single-port robotic nephropexy as a safe and effective minimally invasive treatment with favorable short-term outcomes.

  • Novel cardiac abnormalities observed in CAH patients with tenascin-X haploinsufficiency
    Published: Jun 01, 2026
    Author: Andrea Sappl, Annie M Sriramachandran, Christian Lottspeich, Katharina Vill, Monika Morak, Ann-Christin Welp, Orsela Dervishi, Martin Bidlingmaier, Sonja Kunz, Nicole Reisch

    BACKGROUND: Defects in both CYP21A2 and TNXB genes cause congenital adrenal hyperplasia combined with hypermobility-type Ehlers-Danlos syndrome (EDS), which has been named CAH-X syndrome.

  • UK Medical Cannabis Registry: an updated analysis of clinical outcomes of medicinal cannabis therapy for hypermobility-associated chronic pain
    Published: May 30, 2026
    Author: Mariam Alemi, Simon Erridge, Evonne Clarke, Katy McLachlan, Ross Coomber, Shelley Barnes, Alia Darweish Medniuk, Rahul Guru, Wendy Holden, Mohammed Sajad, Robert Searle, Azfer Usmani, Sanjay Varma, James J Rucker, Michael Platt, Mikael H Sodergren

    CONCLUSION: In this real-world cohort, CBMP treatment was associated with sustained improvements in outcomes for individuals with hypermobility-associated chronic pain. These findings support the need for further controlled studies to determine causality. Key Points • This 24-month real-world study demonstrates sustained improvements in pain, anxiety, and sleep outcomes for patients with hypermobility-associated chronic pain treated with cannabis-based medicinal products, with approximately 60%...

  • Age-related symptom clustering in pediatric hypermobility spectrum disorders: a scoping review
    Published: May 30, 2026
    Author: Phoebe Pochcial, Sarah Cohen Solomon, Katelyn A Bruno, DeLisa Fairweather, Angelica Kinane, Lisa Letzkus, Kelly K Gurka, Ina Stephens, Dacre R T Knight

    CONCLUSIONS: This scoping review maps age-related symptom/comorbidity clusters reported in pediatric hypermobility spectrum disorders, with the aim of informing earlier clinical recognition.

  • Efficacy of Vascular Surgical Interventions in Marfan Syndrome and Ehlers-Danlos Syndrome: A Review of Long-Term Patient Outcomes
    Published: May 28, 2026
    Author: K R Arunvignesh, V Ananthanarayanan, Asish Mathew Joseph, Musunuri Manoj Kumar, Aditi Saxena, Vikram S Amberkar

    CONCLUSION: Specialized surgical interventions significantly improve long-term survival and reduce complications in MFS and EDS patients. Valve-sparing procedures, such as the David technique, represent gold standards for optimizing outcomes. Tailored surgical strategies, combined with advancements in imaging and structured follow-up protocols, are crucial for enhancing patient care. Future research should focus on multicenter trials and integrating genetic and molecular profiling to further...

  • Genetic Causes and Ankle Instability in Hypermobile Ehlers-Danlos Syndrome (hEDS): An Integrated Analysis Using Whole-Exome Sequencing and Stress Imaging
    Published: May 27, 2026
    Author: Jae-Yoon Kim, Ho-Yeon Lee, Seon-Yeop Kim, Sun-Woo Lee, Minjoo Cho, Jeong Woen Shin, Yeo-Gyeong Yoon, Jinhyuk Lee, Yea Eun Kang, Da Hyun Kang, Seong Kyeong Jo, Chan Kang, Namshin Kim, Jae Hwang Song

    Background: Hypermobile Ehlers-Danlos syndrome (hEDS), the most common EDS subtype, is characterized by chronic pain and joint laxity, yet no definitive causative genes or imaging-based diagnostic criteria have been established. This study investigated the genetic basis of hEDS using whole-exome sequencing (WES) and objectively evaluated ankle instability. Methods: We conducted an observational cohort study with a case-control comparison, including 22 patients and a three-generation Korean...

  • Too high and too loose: dysautonomia and the hypertensive paradox in hypermobility disorders
    Published: May 26, 2026
    Author: James W Johnson, Isabella Mirro, Amy R Kontorovich

    PURPOSE OF REVIEW: Hypertension in hypermobile Ehlers-Danlos syndrome (hEDS) and hypermobility spectrum disorders (HSD) represents an increasingly recognized but poorly understood clinical phenomenon. This review addresses the unique pathophysiology, diagnostic considerations, and management challenges of hypertension occurring in the context of dysautonomia - a comorbidity affecting up to 70% of patients with hEDS/HSD.

  • Hypermobility and chronic pain in adolescents: diverging functional and neural profiles without sensory differences
    Published: May 26, 2026
    Author: Katrina Huft, Emma F Gaydos, Jewel N White, Saül Pascual-Diaz, Elke Schubert-Hjalmarsson, Natasha Harrison, Lita Moua, Marie-Eve Hoeppli, Emma Biggs, Jennifer N Stinson, Nima Aghaeepour, Martin S Angst, Brice Gaudilliere, Robert C Coghill, Massieh Moayedi, Marina López-Solá, Christopher D King, Laura E Simons

    Chronic pain (CP) affects approximately 20% of children, significantly impacting their physical, emotional, and social well-being. Hypermobility disorders (HDs) are prevalent in pediatric populations, including those with CP, and often contribute to impairments in psychological and physical functioning. This study examined differences in sensory, functional, and neural circuitry among CP in youth with and without comorbid HD (CP + HD). Contrary to our a priori hypothesis and previous literature...

  • Gastrointestinal involvement in Ehlers-Danlos syndrome classical-like type 2 associated with a novel AEBP1 splice-site variant
    Published: May 26, 2026
    Author: Hikaru Nakahara, Tomomi Yamaguchi, Hiroaki Niitsu, Akiko Abe, Ryohei Hayashi, Shiro Oka, Koji Arihiro, Tomoki Kosho, Takao Hinoi

    Ehlers-Danlos syndrome classical-like type 2 (clEDS2) is a rare autosomal recessive connective tissue disorder caused by biallelic loss-of-function variants in the gene encoding adipocyte enhancer-binding protein 1 (AEBP1). While cutaneous and skeletal manifestations are commonly observed, gastrointestinal complications, including bowel rupture, have been reported only rarely, and their histopathological basis remains poorly characterized. Here, we report findings of molecular investigations,...

Stop searching!

Get information sent directly to your inbox!

Get involved in the movement to help find answers faster through community sharing. #Sharingiscaring

The information provided by EDS S.H.A.R.E. and EDS Joint Effort is not medical advice. It is intended for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding any medical condition. EDS Joint Effort, its producers, and its contents are not liable for any actions taken based on the information provided, and all users agree to hold harmless EDS Joint Effort and all products, producers from any claims arising from the use of the information provided. This information is not designed to replace a physician’s independent judgment about the appropriateness or risks for a given patient. Always consult your doctor about your medical conditions. EDS S.H.A.R.E. does not provide medical advice, diagnosis or treatment. Use of the site is conditional upon your acceptance of our Terms of Use and Privacy Policy as stated.